R.PascualJ
In type 2 diabetes populations across 38 phase III/IV trials, the rate was lower at 19.3% versus 6.5% on placebo
These hormones are vital in regulating appetite, food intake, and glucose metabolism
They actively disrupt the stoichiometry of photosynthetic proteins, degrade PSII, and change the redox state of the plastoquinone pool, resulting in the excessive production and accumulation of ROS, which eventually triggers a cell death that resembles the effector-triggered HR that limits the growth of pathogens 17,23,24,59,60,61
Regeneron is throwing itself into the obesity market, licensing a dual GLP-1/GIP receptor agonist from the Chinese biopharma Hansoh Pharmaceuticals Group
Figure 2 Bidirectional interactions between gut microbiota and GLP-1 receptor agonists in metabolic regulation